1. Home
  2. SSTK vs ASMB Comparison

SSTK vs ASMB Comparison

Compare SSTK & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shutterstock Inc.

SSTK

Shutterstock Inc.

HOLD

Current Price

$16.29

Market Cap

596.1M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.92

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSTK
ASMB
Founded
2003
2005
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
596.1M
440.0M
IPO Year
2012
2010

Fundamental Metrics

Financial Performance
Metric
SSTK
ASMB
Price
$16.29
$28.92
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$25.00
$43.40
AVG Volume (30 Days)
423.5K
93.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.98%
N/A
EPS Growth
23.76
50.00
EPS
1.25
N/A
Revenue
N/A
N/A
Revenue This Year
$4.35
$33.33
Revenue Next Year
N/A
N/A
P/E Ratio
$12.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.35
$7.76
52 Week High
$29.50
$39.71

Technical Indicators

Market Signals
Indicator
SSTK
ASMB
Relative Strength Index (RSI) 43.89 49.12
Support Level $14.36 $26.50
Resistance Level $17.90 $30.66
Average True Range (ATR) 0.73 1.42
MACD 0.04 -0.04
Stochastic Oscillator 32.09 41.44

Price Performance

Historical Comparison
SSTK
ASMB

About SSTK Shutterstock Inc.

Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: